Gregory Dean Givens, the EVP & COO of $OVV, sold 50,000 shares of the company on 12-12-2025 for an estimated $2,016,500. We received data on the trade from a recent SEC filing. This was a sale of approximately 32.1% of their shares of this class of stock. Following this trade, they now own 105,867 shares of this class of $OVV stock.
$OVV Insider Trading Activity
$OVV insiders have traded $OVV stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $OVV stock by insiders over the last 6 months:
- GREGORY DEAN GIVENS (EVP & COO) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $4,141,500.
- STEVEN W NANCE sold 5,000 shares for an estimated $209,950
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OVV Hedge Fund Activity
We have seen 265 institutional investors add shares of $OVV stock to their portfolio, and 377 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,633,181 shares (+135.5%) to their portfolio in Q3 2025, for an estimated $146,707,848
- AQR CAPITAL MANAGEMENT LLC added 3,589,030 shares (+263.8%) to their portfolio in Q3 2025, for an estimated $144,925,031
- AMUNDI removed 2,231,116 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $84,893,963
- FMR LLC added 2,211,999 shares (+11.9%) to their portfolio in Q3 2025, for an estimated $89,320,519
- DIMENSIONAL FUND ADVISORS LP added 1,927,193 shares (+25.8%) to their portfolio in Q3 2025, for an estimated $77,820,053
- MILLENNIUM MANAGEMENT LLC removed 1,837,296 shares (-41.3%) from their portfolio in Q3 2025, for an estimated $74,190,012
- ENCOMPASS CAPITAL ADVISORS LLC removed 1,635,482 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $62,230,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OVV Revenue
$OVV had revenues of $2.1B in Q3 2025. This is a decrease of -11.1% from the same period in the prior year.
You can track OVV financials on Quiver Quantitative's OVV stock page.
$OVV Congressional Stock Trading
Members of Congress have traded $OVV stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OVV stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$OVV Analyst Ratings
Wall Street analysts have issued reports on $OVV in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/21/2025
- Citigroup issued a "Buy" rating on 11/18/2025
- Barclays issued a "Overweight" rating on 10/07/2025
- Evercore ISI Group issued a "Outperform" rating on 10/06/2025
- JP Morgan issued a "Overweight" rating on 10/03/2025
- Mizuho issued a "Outperform" rating on 09/15/2025
- Scotiabank issued a "Sector Outperform" rating on 07/11/2025
To track analyst ratings and price targets for $OVV, check out Quiver Quantitative's $OVV forecast page.
$OVV Price Targets
Multiple analysts have issued price targets for $OVV recently. We have seen 13 analysts offer price targets for $OVV in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Josh Silverstein from UBS set a target price of $55.0 on 12/12/2025
- Neal Dingmann from William Blair set a target price of $50.0 on 11/26/2025
- Scott Gruber from Citigroup set a target price of $52.0 on 11/18/2025
- Roger Read from Wells Fargo set a target price of $42.0 on 11/18/2025
- Greg Pardy from RBC Capital set a target price of $55.0 on 10/15/2025
- Nick Pope from Roth Capital set a target price of $42.0 on 10/14/2025
- Devin McDermott from Morgan Stanley set a target price of $46.0 on 10/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
